Heart failure with preserved ejection fraction
Clinical trials for Heart failure with preserved ejection fraction explained in plain language.
Never miss a new study
Get alerted when new Heart failure with preserved ejection fraction trials appear
Sign up with your email to follow new studies for Heart failure with preserved ejection fraction, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New clinic aims to keep heart failure patients out of the hospital
Disease control Stopped earlyThis study tests a multidisciplinary clinic that provides heart failure patients with educational videos, a self-management kit, and follow-up phone calls after hospital discharge. The goal is to reduce 30-day readmission rates and improve patient satisfaction. The trial enrolls …
Matched conditions: HEART FAILURE WITH PRESERVED EJECTION FRACTION
Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Sep 21, 2026 23:00 UTC
-
New heart failure drug shows promise in Mid-Stage trial
Disease control Stopped earlyThis study tested an investigational drug called LY3540378 in 332 adults with worsening chronic heart failure where the heart pumps normally but doesn't fill properly (HFpEF). The goal was to see if the drug could improve heart function and safety compared to a placebo. The trial…
Matched conditions: HEART FAILURE WITH PRESERVED EJECTION FRACTION
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Heart failure drug trial halted early – what went wrong?
Disease control Stopped earlyThis small study tested a drug called PL-3994 in 15 people with a type of heart failure where the heart pumps normally but doesn't relax properly. The goal was to see if the drug improved heart function and if effects differed between men and women. The trial was terminated early…
Matched conditions: HEART FAILURE WITH PRESERVED EJECTION FRACTION
Phase 2 • Sponsor: Palatin Technologies, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Heart failure drug trial ends early – only 4 patients enrolled
Disease control Stopped earlyThis was a very early (Phase 1) study testing a drug called HS135 in obese patients who have both pulmonary hypertension and a type of heart failure called HFpEF. The trial was terminated after enrolling only 4 people, so we have no useful information on whether HS135 is safe or …
Matched conditions: HEART FAILURE WITH PRESERVED EJECTION FRACTION
Phase 1 • Sponsor: 35Pharma Inc • Aim: Disease control
Last updated Jun 26, 2026 14:09 UTC
-
Virtual exercise coach tested for heart failure – but trial stops early
Symptom relief Stopped earlyThis study tested a program called HEART Camp Connect, which uses a virtual coach to help adults with heart failure exercise 150 minutes per week. Only 11 people enrolled before the trial was stopped. Researchers wanted to see if the program improved exercise habits and heart-rel…
Matched conditions: HEART FAILURE WITH PRESERVED EJECTION FRACTION
Sponsor: University of Nebraska • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Hidden heart condition: study seeks to uncover missed diagnosis in heart failure patients
Knowledge-focused Stopped earlyThis study aims to find out how common transthyretin amyloidosis cardiomyopathy (ATTR-CM) is in Russian patients with a certain type of heart failure. Researchers will review medical records and then invite some patients for extra heart tests to confirm or rule out ATTR-CM. The g…
Matched conditions: HEART FAILURE WITH PRESERVED EJECTION FRACTION
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:47 UTC